Van Eck Associates Corp Novartis Ag Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Novartis Ag stock. As of the latest transaction made, Van Eck Associates Corp holds 310,713 shares of NVS stock, worth $31.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

310,713

Previous 286,590 8.42%

Holding current value

$31.1 Million

Previous $30.5 Million 16.17%

% of portfolio

0.04%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$106.13 - $120.89 $2.56 Million - $2.92 Million	24,123 Added 8.42%	310,713 $35.4 Million
Q2 2024 Jul 31, 2024	BUY	$92.57 - $107.37 $1.5 Million - $1.73 Million	16,150 Added 5.97%	286,590 $30.5 Million
Q1 2024 Apr 30, 2024	BUY	$95.27 - $108.47 $5.25 Million - $5.98 Million	55,142 Added 25.61%	270,440 $26.2 Million
Q4 2023 Feb 05, 2024	SELL	$92.27 - $101.54 $443,910 - $488,508	-4,811 Reduced 2.19%	215,298 $21.7 Million
Q3 2023 Nov 08, 2023	BUY	$94.73 - $105.13 $2.77 Million - $3.08 Million	29,252 Added 15.33%	220,109 $22.4 Million
Q2 2023 Aug 03, 2023	SELL	$92.52 - $104.91 $2.21 Million - $2.51 Million	-23,920 Reduced 11.14%	190,857 $19.3 Million
Q1 2023 May 03, 2023	SELL	$80.03 - $92.81 $8.23 Million - $9.55 Million	-102,878 Reduced 32.39%	214,777 $19.8 Million
Q4 2022 Feb 08, 2023	SELL	$75.55 - $92.52 $1.7 Million - $2.09 Million	-22,560 Reduced 6.63%	317,655 $28.8 Million
Q3 2022 Oct 27, 2022	SELL	$74.61 - $87.26 $223,009 - $260,820	-2,989 Reduced 0.87%	340,215 $25.9 Million
Q2 2022 Aug 03, 2022	BUY	$80.52 - $93.75 $9.96 Million - $11.6 Million	123,649 Added 56.32%	343,204 $29 Million
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $152,209 - $172,178	1,900 Added 0.87%	219,555 $19.3 Million
Q4 2021 Jan 26, 2022	BUY	$79.7 - $88.13 $2.22 Million - $2.46 Million	27,874 Added 14.69%	217,655 $19 Million
Q3 2021 Nov 03, 2021	BUY	$81.78 - $95.14 $5.04 Million - $5.87 Million	61,671 Added 48.14%	189,781 $15.5 Million
Q2 2021 Aug 10, 2021	SELL	$85.24 - $94.15 $809,609 - $894,236	-9,498 Reduced 6.9%	128,110 $11.7 Million
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $11,272 - $13,293	135 Added 0.1%	137,608 $11.8 Million
Q4 2020 Feb 09, 2021	BUY	$78.07 - $94.43 $278,475 - $336,831	3,567 Added 2.66%	137,473 $13 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $12,156 - $13,468	-148 Reduced 0.11%	133,906 $11.6 Million
Q2 2020 Aug 10, 2020	BUY	$80.93 - $91.1 $1.68 Million - $1.9 Million	20,817 Added 18.38%	134,054 $11.7 Million
Q1 2020 May 12, 2020	BUY	$70.67 - $99.01 $496,880 - $696,139	7,031 Added 6.62%	113,237 $9.34 Million
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $2.12 Million - $2.39 Million	25,077 Added 30.91%	106,206 $10.1 Million
Q3 2019 Nov 08, 2019	SELL	$85.54 - $94.26 $1.32 Million - $1.45 Million	-15,427 Reduced 15.98%	81,129 $7.05 Million
Q2 2019 Aug 07, 2019	SELL	$75.4 - $92.8 $536,998 - $660,921	-7,122 Reduced 6.87%	96,556 $8.82 Million
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $2.84 Million - $3.25 Million	-37,759 Reduced 26.7%	103,678 $9.97 Million
Q4 2018 Feb 12, 2019	SELL	$73.66 - $82.02 $1.34 Million - $1.5 Million	-18,254 Reduced 11.43%	141,437 $12.1 Million
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $1.74 Million - $2.01 Million	-25,973 Reduced 13.99%	159,691 $13.8 Million
Q2 2018 Aug 13, 2018	BUY	$64.91 - $73.36 $2.12 Million - $2.4 Million	32,669 Added 21.35%	185,664 $14 Million
Q1 2018 May 11, 2018	SELL	$70.39 - $84.15 $622,036 - $743,633	-8,837 Reduced 5.46%	152,995 $12.4 Million
Q4 2017 Feb 12, 2018	SELL	$72.33 - $77.64 $144,587 - $155,202	-1,999 Reduced 1.22%	161,832 $13.6 Million
Q3 2017 Nov 09, 2017	SELL	$74.14 - $77.27 $3.89 Million - $4.05 Million	-52,447 Reduced 24.25%	163,831 $14.1 Million
Q2 2017 Aug 11, 2017	BUY	N/A	216,278	216,278 $18.1 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $216B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Novartis Ag Transaction History